EMVISION MEDICAL DEVICES LTD

3.26%

$1.93

Market Cap $165.0M

Technology Scientific & Technical Instruments

EMVision Medical Devices Limited is an Australian medical device company. The Company is... EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Latest Threads

Tag

Subject

EMV

EMV Chart

04/09/25

300

04/09/25

Last post shane88

300

EMV

EMvision Research Notes

51 52 53

04/09/25

3.1K

1.5M

04/09/25

Last post SA1588

3.1K

1.5M

EMV

Ann: UCLA Health Activation & Continuous Innovation Study Update

28/08/25

3.5K

28/08/25

Last post Eire2011

3.5K

EMV

Ann: Appendix 4E & Annual Report to 30 June 2025

28/08/25

738

28/08/25

Last post chaddy36

738

EMV

Ann: Appendix 4G & Corporate Governance Statement

28/08/25

165

28/08/25

Last post

ASX News

165

EMV

Ann: EMVision Awarded $3m Grant For Regional Benefits Study

15/08/25

4.2K

15/08/25

Last post djkencloud

4.2K

EMV

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

11/08/25

14K

11/08/25

Last post DiscoWarrior

14K

EMV

Ann: Notification regarding unquoted securities - EMV

11/08/25

309

11/08/25

Last post

ASX News

309

See All Discussions

Timeline

Appendix 4G & Corporate Governance Statement
28 Aug 09:38	Share

Appendix 4E & Annual Report to 30 June 2025
28 Aug 09:37	Share

UCLA Health Activation & Continuous Innovation Study Update
26 Aug 09:14	Share

EMVision Awarded $3m Grant For Regional Benefits Study
15 Aug 09:09	Share

Notification regarding unquoted securities - EMV
11 Aug 15:39	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Jul 08:17	Share

First Responder Program Advanced & Grant Milestone Achieved
29 Jul 08:40	Share

Key Developments in Pivotal Trial & Innovation Study
02 Jul 08:21	Share

EMVision Awarded $5m Non-Dilutive Government Grant
16 Jun 08:28	Share

Non-Executive Director Appointment
05 Jun 08:20	Share

Initial Director's Interest Notice
05 Jun 08:20	Share

Additional Pivotal Trial Site Activations
03 Jun 08:22	Share

Enhanced Algorithm Performance From Continuous Innovation
21 May 08:42	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 08:08	Share

Activation of Second US Pivotal Trial Site, Mayo Clinic
28 Apr 08:25	Share

Final Director's Interest Notice
16 Apr 09:04	Share

Non-Executive Director Retirement
16 Apr 09:03	Share

Emu Pivotal Validation Trial Commences
27 Mar 08:15	Share

Change of Share Registry Details
21 Mar 17:16	Share

First Responder Scanner in Successful Aeromedical Testing
19 Mar 08:17	Share

S&P DJI Announces March 2025 Quarterly Rebalance
07 Mar 17:01	Share

EMVision Releases its FY25 Half Yearly Report
27 Feb 14:56	Share

Half Yearly Report and Accounts
27 Feb 14:56	Share

US Ethics Approval Received for Pivotal Validation Trial
12 Feb 08:19	Share

Quarterly Activities/Appendix 4C Cash Flow Report
28 Jan 08:54	Share

EMVision Receives $2.12m R&D Tax Rebate
20 Jan 08:22	Share

Notification of cessation of securities - EMV
02 Dec 08:20	Share

Presentation - Ord Minnett Biotech & Medtech Conference
28 Nov 09:06	Share

Change of Director's Interest Notice
20 Nov 12:58	Share

Notification regarding unquoted securities - EMV
20 Nov 12:55	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.93		Change -0.065(3.26%)		Mkt cap ! $165.0M

Open	High	Low	Value	Volume
$1.96	$2.02	$1.93	$46.90K	23.68K

Buyers (Bids)

No.	Vol.	Price($)
1	4999	$1.93

Sellers (Offers)

Price($)	Vol.	No.
$2.01	7795	1

View Market Depth

No.	Vol.	Price($)
1	4999	1.930
1	5000	1.920
1	12000	1.900
1	12000	1.880
1	7870	1.860

Price($)	Vol.	No.
2.010	7795	1
2.020	10000	1
2.040	1960	1
2.060	3136	1
2.080	23312	1

Last trade - 16.10pm 04/09/2025 (20 minute delay)

EMV (ASX) Chart

EMVISION MEDICAL DEVICES LTD

Latest Threads

Timeline

Featured News

Latest Videos

EMVision Medical Devices (ASX:EMV) completes stage one brain scan trial enrolment

21 Feb 2023 10:30 (AEDT)

EmVision Medical Devices (ASX:EMV) progresses clinical trial with 50pc patient enrolment

25 Jan 2023 12:26 (AEDT)

Latest Articles

EMVision sends off bedside brain scan device to Mayo Clinic for second test site

EMVision, seeking to disrupt the brain scanner tech space, has sent off a second 'Emu' bedside scanner to a US-based Mayo Clinic.

EMVision Medical successfully fabs first prototype of First Responder brain scan device – portable enough for a backpack

EMVision Medical Devices (ASX:EMV) has announced its successful fabrication of a portable on-the-spot brain scanning device.

EMVision unveils first point-of-care brain scanner device at RSNA 2023

EMVision Medical Devices (ASX:EMV) has revealed the name of its inaugural point-of-care brain scanner device, 'emu', at the RSNA 2023 conference.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News